Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Ronidazole in the Treatment of Trichomonad Infections in Cats

Author(s):  Davidson Gigi S

Issue:  Nov/Dec 2006 - Veterinary Compounding
View All Articles in Issue

Abstract:  Tritrichomonas foetus, a microscopic single-celled flagellated protozoan parasite, traditionally identified as a cause of reproductive disease in cattle, has been demonstrated as an important cause of diarrhea in cats. Until recently, an effective antimicrobial treatment for feline Tritrichomonas foetus had not been identified. Since recommended dosages of antimicrobial drugs have failed in cats infected with Tritrichomonas foetus and in vitro studies have revealed multiple drug resistance, investigations continue in the effort to find an effective treatment. One particular study by Dr. Jody Gookin noted no clinicopathological abnormalities or adverse effects with the use of ronidazole, and the research concluded that ronidazole administered at 30 to 50 mg/kg orally twice daily for 2 weeks was capable of resolving diarrhea and eradicating infections of Tritrichomonas foetus in cats. Clinical use of ronidazole has revealed a reversible, possibly dose-related, neurotoxicity. Cats receiving ronidazole should be

Related Keywords: Gigi S Davison, BS, RPh, FSVHP, DICVP, cats, Tritrichomonas foetus, trichomonad infection, protozoa, parasites, parasitic infection, ronidazole, antibiotics, antimicrobial agent, antiparasitic agent, diarrhea, adverse effects, side effects, drug safety, neurotoxicity, nystagmus, ataxia, behavioral disorders, dosage forms, dosing, veterinary


Printer-Friendly Version

Download in electronic PDF format for $65

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Ronidazole in the Treatment of Trichomonad Infections in Cats Davidson Gigi S Nov/Dec 2006 434-435 Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310-312 Buy
Compounding for Treatment of Equine Infectious Diseases: An Overview Bramwell Bethany L Nov/Dec 2011 450-457 Buy
Compounding for the Effects of Weapons of Mass Destruction Sammarco Domenic A Jan/Feb 2003 10-15 View Sample
Aztreonam Injection Allen Loyd V Jr Jan/Feb 2014 60 Buy
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Allen W Chris, Greeson Nicole MH, Mixon William Nov/Dec 2020 451-458 Buy
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane Jan/Feb 2017 22-27 Buy
Basics of Compounding for Terrorist Attacks, Part 2 Allen Loyd V Jr Mar/Apr 2003 129-134 View Sample
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Ploesser Jennifer, Weinstock Leonard B, Thomas Erin Mar/Apr 2010 171-173 Buy
Compounding for Feline Herpetic Keratitis Davidson Gigi S Nov/Dec 2006 411-414 Buy
Particle Measuring Systems - USP <797> Environmental Monitoring Solutions